Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · IEX Real-Time Price · USD
9.09
-0.15 (-1.62%)
Apr 24, 2024, 11:01 AM EDT - Market open

Fennec Pharmaceuticals Statistics

Total Valuation

FENC has a market cap or net worth of $245.49 million. The enterprise value is $266.87 million.

Market Cap 245.49M
Enterprise Value 266.87M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

FENC has 27.10 million shares outstanding. The number of shares has increased by 1.14% in one year.

Shares Outstanding 27.10M
Shares Change (YoY) +1.14%
Shares Change (QoQ) +0.49%
Owned by Insiders (%) 14.60%
Owned by Institutions (%) 55.24%
Float 15.29M

Valuation Ratios

PE Ratio n/a
Forward PE 17.29
PS Ratio 11.78
Forward PS 4.19
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 12.56
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.56

Current Ratio 3.56
Quick Ratio 2.92
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.73

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -73.60%
Return on Capital (ROIC) -70.51%
Revenue Per Employee $732,828
Profits Per Employee -$553,276
Employee Count 29
Asset Turnover 0.98
Inventory Turnover 0.92

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +13.23% in the last 52 weeks. The beta is 0.40, so FENC's price volatility has been lower than the market average.

Beta (1Y) 0.40
52-Week Price Change +13.23%
50-Day Moving Average 10.02
200-Day Moving Average 8.94
Relative Strength Index (RSI) 28.49
Average Volume (30 Days) 131,400

Short Selling Information

The latest short interest is 1.81 million, so 6.69% of the outstanding shares have been sold short.

Short Interest 1.81M
Short Previous Month 1.69M
Short % of Shares Out 6.69%
Short % of Float 11.86%
Short Ratio (days to cover) 11.17

Income Statement

In the last 12 months, FENC had revenue of $21.25 million and -$16.05 million in losses. Loss per share was -$0.60.

Revenue 21.25M
Gross Profit 19.99M
Operating Income -12.77M
Pretax Income -16.05M
Net Income -16.05M
EBITDA -12.65M
EBIT -12.65M
Loss Per Share -$0.60
Full Income Statement

Balance Sheet

The company has $13.27 million in cash and $29.74 million in debt, giving a net cash position of -$16.47 million or -$0.61 per share.

Cash & Cash Equivalents 13.27M
Total Debt 29.74M
Net Cash -16.47M
Net Cash Per Share -$0.61
Equity / Book Value -11.62M
Book Value Per Share -0.43
Working Capital 19.31M
Full Balance Sheet

Cash Flow

Operating Cash Flow -17.14M
Capital Expenditures n/a
Free Cash Flow -17.14M
FCF Per Share -$0.65
Full Cash Flow Statement

Margins

Gross margin is 94.08%, with operating and profit margins of -60.09% and -75.50%.

Gross Margin 94.08%
Operating Margin -60.09%
Pretax Margin -75.50%
Profit Margin -75.50%
EBITDA Margin -59.53%
EBIT Margin -59.53%
FCF Margin -80.67%

Dividends & Yields

FENC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.14%
Shareholder Yield -1.14%
Earnings Yield -6.41%
FCF Yield -6.85%

Analyst Forecast

The average price target for FENC is $18.00, which is 98.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target $18.00
Price Target Difference 98.02%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 59.64%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 1:3.

Last Split Date Sep 5, 2014
Split Type Reverse
Split Ratio 1:3

Scores

FENC has an Altman Z-Score of -7.42 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.42
Piotroski F-Score 1